259 related articles for article (PubMed ID: 12225794)
1. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
Greiner J; Ringhoffer M; Taniguchi M; Schmitt A; Kirchner D; Krähn G; Heilmann V; Gschwend J; Bergmann L; Döhner H; Schmitt M
Exp Hematol; 2002 Sep; 30(9):1029-35. PubMed ID: 12225794
[TBL] [Abstract][Full Text] [Related]
2. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.
Greiner J; Ringhoffer M; Taniguchi M; Hauser T; Schmitt A; Döhner H; Schmitt M
Int J Cancer; 2003 Aug; 106(2):224-31. PubMed ID: 12800198
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.
Greiner J; Li L; Ringhoffer M; Barth TF; Giannopoulos K; Guillaume P; Ritter G; Wiesneth M; Döhner H; Schmitt M
Blood; 2005 Aug; 106(3):938-45. PubMed ID: 15827130
[TBL] [Abstract][Full Text] [Related]
5. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.
Snauwaert S; Vanhee S; Goetgeluk G; Verstichel G; Van Caeneghem Y; Velghe I; Philippé J; Berneman ZN; Plum J; Taghon T; Leclercq G; Thielemans K; Kerre T; Vandekerckhove B
Haematologica; 2012 Oct; 97(10):1539-47. PubMed ID: 22532518
[TBL] [Abstract][Full Text] [Related]
6. Frequency of expression of RHAMM/CD168 in Egyptian patients with CML.
Gouda HM; Abdel Mohsen MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):93-9. PubMed ID: 21057560
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
Li L; Reinhardt P; Schmitt A; Barth TF; Greiner J; Ringhoffer M; Döhner H; Wiesneth M; Schmitt M
Cancer Immunol Immunother; 2005 Jul; 54(7):685-93. PubMed ID: 15627212
[TBL] [Abstract][Full Text] [Related]
8. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.
Willemen Y; Van den Bergh JM; Bonte SM; Anguille S; Heirman C; Stein BM; Goossens H; Kerre T; Thielemans K; Peeters M; Van Tendeloo VF; Smits EL; Berneman ZN
Oncotarget; 2016 Nov; 7(45):73960-73970. PubMed ID: 27659531
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
Greiner J; Ringhoffer M; Taniguchi M; Li L; Schmitt A; Shiku H; Döhner H; Schmitt M
Int J Cancer; 2004 Feb; 108(5):704-11. PubMed ID: 14696097
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation.
Casalegno-Garduño R; Meier C; Schmitt A; Spitschak A; Hilgendorf I; Rohde S; Hirt C; Freund M; Pützer BM; Schmitt M
Clin Dev Immunol; 2012; 2012():146463. PubMed ID: 22719778
[TBL] [Abstract][Full Text] [Related]
11. The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.
Schmitt A; Barth TF; Beyer E; Borchert F; Rojewski M; Chen J; Guillaume P; Gronau S; Greiner J; Möller P; Riechelmann H; Schmitt M
Int J Oncol; 2009 Mar; 34(3):629-39. PubMed ID: 19212667
[TBL] [Abstract][Full Text] [Related]
12. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia.
Greiner J; Ringhoffer M; Simikopinko O; Szmaragowska A; Huebsch S; Maurer U; Bergmann L; Schmitt M
Exp Hematol; 2000 Dec; 28(12):1413-22. PubMed ID: 11146163
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells.
Fukui M; Ueno K; Suehiro Y; Hamanaka Y; Imai K; Hinoda Y
Cancer Immunol Immunother; 2006 May; 55(5):538-46. PubMed ID: 16025267
[TBL] [Abstract][Full Text] [Related]
17. Bio-electric field enhancement: the influence on hyaluronan mediated motility receptors in human breast carcinoma.
Purnell MC
Discov Med; 2017 Apr; 23(127):259-267. PubMed ID: 28595038
[TBL] [Abstract][Full Text] [Related]
18. Beta1-integrins control spontaneous adhesion and motility of human progenitor thymocytes and regulate differentiation-dependent expression of the receptor for hyaluronan-mediated motility.
Gares SL; Pilarski LM
Scand J Immunol; 1999 Dec; 50(6):626-34. PubMed ID: 10607311
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
20. Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia.
Kanojia D; Garg M; Saini S; Agarwal S; Kumar R; Suri A
Leuk Res; 2010 Jul; 34(7):858-63. PubMed ID: 20138665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]